Scientists hunt for blood clues to explain why brittle bone disease varies so much
NCT ID NCT04009733
Summary
This study aimed to understand why osteogenesis imperfecta (brittle bone disease) varies in severity from person to person. Researchers analyzed blood samples from 66 adults with different forms of the disease to look for tiny molecules called microRNAs that might be linked to how severe the condition is. The goal was to find biological markers that could help explain the differences in bone fractures, pain, and quality of life among patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOGENESIS IMPERFECTA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Edouard Herriot
Lyon, 69003, France
Conditions
Explore the condition pages connected to this study.